Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy

J Rheumatol. 2011 Mar;38(3):579-80. doi: 10.3899/jrheum.100968.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Psoriatic / drug therapy
  • Estradiol / blood
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Thyroiditis / chemically induced*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Vasculitis / chemically induced*
  • Vitiligo / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Estradiol
  • Infliximab